<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(1)</volume><submitter>Randeria SN</submitter><funding>South African National Research Foundation</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The global burden of type 2 diabetes mellitus (T2DM), together with the presence of cardiovascular risk in this population, is reaching pandemic levels. A prominent feature of T2DM is chronic and systemic inflammation, with the accompanying presence of circulating and dysregulated inflammatory biomarkers; which in turn is associated with abnormal clot formation.&lt;h4>Methods&lt;/h4>Here, we investigate the correlation between abnormal blood clotting, using thromboelastography (TEG), clot ultrastructure using scanning electron microscopy (SEM) and the presence of a dysregulated inflammatory cytokine profile, by examining various circulating biomarkers.&lt;h4>Results&lt;/h4>Our results show that many biomarkers, across TEG, cytokine and lipid groups, were greatly dysregulated in the </pubmed_abstract><journal>Cardiovascular diabetology</journal><pagination>72</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6549308</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation.</pubmed_title><pmcid>PMC6549308</pmcid><pubmed_authors>Roberts T</pubmed_authors><pubmed_authors>Randeria SN</pubmed_authors><pubmed_authors>Nell TA</pubmed_authors><pubmed_authors>Pretorius E</pubmed_authors><pubmed_authors>Thomson GJA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation.</name><description>&lt;h4>Background&lt;/h4>The global burden of type 2 diabetes mellitus (T2DM), together with the presence of cardiovascular risk in this population, is reaching pandemic levels. A prominent feature of T2DM is chronic and systemic inflammation, with the accompanying presence of circulating and dysregulated inflammatory biomarkers; which in turn is associated with abnormal clot formation.&lt;h4>Methods&lt;/h4>Here, we investigate the correlation between abnormal blood clotting, using thromboelastography (TEG), clot ultrastructure using scanning electron microscopy (SEM) and the presence of a dysregulated inflammatory cytokine profile, by examining various circulating biomarkers.&lt;h4>Results&lt;/h4>Our results show that many biomarkers, across TEG, cytokine and lipid groups, were greatly dysregulated in the </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jun</publication><modification>2025-04-19T14:27:37.765Z</modification><creation>2019-07-24T07:10:02Z</creation></dates><accession>S-EPMC6549308</accession><cross_references><pubmed>31164120</pubmed><doi>10.1186/s12933-019-0870-9</doi></cross_references></HashMap>